Beauty Health (SKIN)
NASDAQ:SKIN
Want to see SKIN full AI Analyst Report?
SKIN Stock Chart & Stats
$0.91
-$0.07(-3.95%)
At close: 4:00 PM EST
$0.91
-$0.07(-3.95%)
Day’s Range― - ―
52-Week Range$0.55 - $2.69
Previous CloseN/A
Volume138.49K
Average Volume (3M)1.04M
Market Cap
$87.80M
Enterprise Value$250.60M
Total Cash (Recent Filing)$204.40M
Total Debt (Recent Filing)$367.20M
Price to Earnings (P/E)―
Beta1.89
Next Earnings
Aug 11, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding129,600,040
10 Day Avg. Volume926,645
30 Day Avg. Volume1,036,656
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)2.88
Price to Sales (P/S)0.58
P/FCF Ratio4.72
Enterprise Value/Market Cap2.85
Enterprise Value/Revenue0.85
Enterprise Value/Gross Profit1.30
Enterprise Value/Ebitda5.85
Forecast
1Y Price Target
$1.50Price Target Upside64.84% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)-0.15
Revenue Forecast (FY)$289.90M
Bulls Say, Bears Say
Bulls Say
Balance Sheet FlexibilityA strong cash position combined with low capital expenditure needs gives flexibility to fund strategic priorities and pursue growth without relying on external financing.
Consumables And Recurring RevenueReturn to growth in consumables, supported by higher pricing and premium add-ons, bolsters a more predictable recurring revenue stream that can offset equipment cyclicality.
Profitability / MarginsReduced operating expenses expanded adjusted profit margins, improving profitability and creating scope for stronger earnings as top-line pressure eases.
Bears Say
Capital Equipment DemandMacro-driven weakness in capital equipment ordering and management's decision to reinvest margins could limit near-term revenue and earnings expansion.
Delivery Systems And Regional ExposurePressure on delivery system revenues from a weak macro and credit environment, combined with softness in China, is weighing on new device placements and sales momentum.
Visibility And Adoption RiskLimited visibility into consistent improvement in new device placements and device utilization supports analyst caution and constrains upside until clearer adoption trends emerge.
Beauty Health News
SKIN FAQ
What was Beauty Health’s price range in the past 12 months?
Beauty Health lowest stock price was $0.55 and its highest was $2.69 in the past 12 months.
What is Beauty Health’s market cap?
Beauty Health’s market cap is $87.80M.
When is Beauty Health’s upcoming earnings report date?
Beauty Health’s upcoming earnings report date is Aug 11, 2026 which is in 82 days.
How were Beauty Health’s earnings last quarter?
Beauty Health released its earnings results on May 07, 2026. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.074 by $0.024.
Is Beauty Health overvalued?
According to Wall Street analysts Beauty Health’s price is currently Undervalued.
Does Beauty Health pay dividends?
Beauty Health does not currently pay dividends.
What is Beauty Health’s EPS estimate?
Beauty Health’s EPS estimate is -0.02.
How many shares outstanding does Beauty Health have?
Beauty Health has 129,600,040 shares outstanding.
What happened to Beauty Health’s price movement after its last earnings report?
Beauty Health reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.074. Following the earnings report the stock price went down -36.264%.
Which hedge fund is a major shareholder of Beauty Health?
Currently, no hedge funds are holding shares in SKIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.50 (64.84% Upside)
$1.50 (64.84% Upside)
Hedge Fund Trend
Decreased
By 604.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.85%
12-Months-Change
Fundamentals
Return on Equity
-9.41%
Trailing 12-Months
Asset Growth
-29.77%
Trailing 12-Months
Company Description
Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
SKIN Company Deck
SKIN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: operational and financial discipline produced a notable EBITDA beat, margin expansion, improved installed base metrics, and strong liquidity, but top-line performance remains pressured with declining sales, softer device placements, and structural macro/competitive headwinds. Management is taking concrete commercial and product actions and maintained EBITDA guidance while trimming revenue expectations, positioning 2026 as an execution/stabilization year with recovery expected in 2027.View all SKIN earnings summariesSKIN Stock 12 Month Forecast
Average Price Target
$1.50
▲(64.84% Upside)
Technical Analysis
Ownership Overview
15.74% Insiders
11.09% Mutual Funds
23.13% Other Institutional Investors
42.43% Public Companies and
Individual Investors